Sanofi [clinicaltrials_resource:26fba9456e1e33d5671ff7055ed23621]
Masayoshi KOYAMA [clinicaltrials_resource:01dfff0485204313fc92c0629dd3df5b]Katrin Roscher [clinicaltrials_resource:0229e2d6d628ea3ce230529d4b618971]Dr. Christian Fassotte, M.D. [clinicaltrials_resource:03803680c50bac7443c79180028a9b0c]José Mª Taboada [clinicaltrials_resource:044e4db38757bb75eb725502e35e5093]Sanni Lahdenpera [clinicaltrials_resource:089a72d1418a4ff3db4eb99ff98c663f]Volodymyr Moshchych [clinicaltrials_resource:0bd0537c77aac6f9fc734e26c9cbdd6d]Martin Thoenes [clinicaltrials_resource:0bdbb7731ecade91c8fbe2cb4c281230]Nathalie Genes, MD [clinicaltrials_resource:0c85d6007f209832ef18e39ab81c640d]Lisa ARVANITIS, MD [clinicaltrials_resource:0f163d5d73bca32d66d919b1f9d4af55]Carlos Santos, MD [clinicaltrials_resource:0f80cc7d4f152db490c11971d518412c]David WHEATLEY [clinicaltrials_resource:0f9e1f45f146aa9554335c5ebdb202bc]Sanjay Aggarwal, MD [clinicaltrials_resource:17a9594d79ead8ae1604ca07752d7a07]COUDERC, Dr [clinicaltrials_resource:19c7de7d2989267f2468151886e08715]Fiona Howard [clinicaltrials_resource:1cdb0fed32c740b449e2a9e387726e22]Pingkuan Zhang [clinicaltrials_resource:1e32d3a824abdf89d3226bb692f815ba]Valerie Lameyre [clinicaltrials_resource:1ee746d625a62d068cc6949b0da5b5e9]Margarita MURRIETA-AGUTTES [clinicaltrials_resource:20648b5899391e9e87398fd1189cd4ad]Judith Diaz [clinicaltrials_resource:20ca20e6dd77c29c15b43f502473bba1]Hyang Rim Kim [clinicaltrials_resource:2129eeffaf377a1bd4c5a191c69410bb]Mary Tzortzis [clinicaltrials_resource:23f87203842c8f8ffa10feee336d8208]Marie Sebille [clinicaltrials_resource:272247de3662ad1b083308542be44087]Phyllis Diener, BS, MT (ASCP) [clinicaltrials_resource:274a6b8a75d97c072420a6ca564c10ff]Nathalie Billon [clinicaltrials_resource:28ebf3425765836b4a31be3e2e0b35ae]William Berg, MD [clinicaltrials_resource:29b5c9dd32b6920365a141c393b527ee]Valerie Pilorget, MD [clinicaltrials_resource:29e07cec304806146166905bc89c5d6f]Iris CHAN, MD [clinicaltrials_resource:2a515c5b35b3456157e445369c9f17b0]E Hens [clinicaltrials_resource:2b50f97a171b41f57e44f30a6cc37293]Sharon Chang [clinicaltrials_resource:2de458d2aa38466556091c6d665d0d7e]Stan Glezer [clinicaltrials_resource:2f5ed593bbb6924b447faf2f1295898c]Valérie Lameyre [clinicaltrials_resource:3156d694c293cc7694a67e6c3aab0d24]Rosanna DUFFY [clinicaltrials_resource:327a7d6cd61cedcaeb69682f7b96e9a6]Georges Paizis, MD [clinicaltrials_resource:3287e2ecbde4ae4f188c411a31f17ed1]PILORGET Valérie, MD [clinicaltrials_resource:373d4622260b7fc65828c9c0ab9790ce]International Clinical Development Study Director [clinicaltrials_resource:385fbc42423f24ce7b1dedfda7499cc4]Daniel Ter-Minassian, MD [clinicaltrials_resource:3a37a2a5eb7260ab347e83c216b39ee2]Zeynep Cetin [clinicaltrials_resource:3b565d9d9c561d77efdaa0109678a544]Ji Young Ahn [clinicaltrials_resource:3b6027e2e4c5382ab60855422307e24d]Lisa Jean-Louis [clinicaltrials_resource:3b958e755d3541aa7a9fc43ce78c569e]Elisabeth SOUHAMI, M.D [clinicaltrials_resource:3daa93af48d3f39774101f68d7d9372d]Rezaul Farid Khan, Medical Director [clinicaltrials_resource:3df3133a3db49729daf64ea76a33aa93]
affiliation [clinicaltrials_vocabulary:affiliation]
clinicaltrials:NCT00021255clinicaltrials:NCT00069784Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO) [clinicaltrials:NCT00115375]OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women [clinicaltrials:NCT00130403]CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease [clinicaltrials:NCT00174759]clinicaltrials:NCT00174837Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) [clinicaltrials:NCT00243178]clinicaltrials:NCT00249795clinicaltrials:NCT00249873Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma [clinicaltrials:NCT00254956]RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment [clinicaltrials:NCT00258921]AMISH : Aprovel for Management of Isolated Systolic Hypertension [clinicaltrials:NCT00264212]Irbesartan in Hypertension [clinicaltrials:NCT00265967]IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment) [clinicaltrials:NCT00268632]Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC] [clinicaltrials:NCT00268710]Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma [clinicaltrials:NCT00270348]APROVE : Irbesartan in Hypertension [clinicaltrials:NCT00283036]clinicaltrials:NCT00284141ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation [clinicaltrials:NCT00296218]PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome [clinicaltrials:NCT00296803]clinicaltrials:NCT00312208clinicaltrials:NCT00319592Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation [clinicaltrials:NCT00325390]clinicaltrials:NCT00327171clinicaltrials:NCT00327444Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria [clinicaltrials:NCT00334581]clinicaltrials:NCT00335452I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients [clinicaltrials:NCT00335673]Risedronate in Osteopenic Postmenopausal Women [clinicaltrials:NCT00345644]Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions [clinicaltrials:NCT00350038]Risedronate in Postmenopausal Women With Low Bone Density [clinicaltrials:NCT00351091]Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women [clinicaltrials:NCT00353080]clinicaltrials:NCT00356122Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women [clinicaltrials:NCT00358176]ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis" [clinicaltrials:NCT00360386]I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular Hypertrophy [clinicaltrials:NCT00362037]I PREVENT - Irbesartan In Hypertensive Diabetic Patients [clinicaltrials:NCT00362258]clinicaltrials:NCT00396591clinicaltrials:NCT00396877Risedronate in the Prevention of Osteoporosis in Postmenopausal Women [clinicaltrials:NCT00402441]
collaborator [clinicaltrials_vocabulary:collaborator]
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00008281]Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT00012389]Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [clinicaltrials:NCT00017459]clinicaltrials:NCT00021255Clinical Trial in Males With BPH (Enlarged Prostate) [clinicaltrials:NCT00029822]Obese Patients With Untreated Dyslipidemias [clinicaltrials:NCT00029835]Obese Patients With Type 2 Diabetes [clinicaltrials:NCT00029848]Obese Patients With or Without Comorbidities (RIO-North America) [clinicaltrials:NCT00029861]Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [clinicaltrials:NCT00032734]Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT). [clinicaltrials:NCT00032747]SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes [clinicaltrials:NCT00043784]Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione [clinicaltrials:NCT00044447]Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [clinicaltrials:NCT00044811]Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [clinicaltrials:NCT00044824]Long-Term Safety Performance of Fexofenadine in Asthma [clinicaltrials:NCT00045955]12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes. [clinicaltrials:NCT00046150]Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment [clinicaltrials:NCT00046462]Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents [clinicaltrials:NCT00046501]Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) [clinicaltrials:NCT00050817]clinicaltrials:NCT00053482clinicaltrials:NCT00053495SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism [clinicaltrials:NCT00062803]Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) [clinicaltrials:NCT00067093]clinicaltrials:NCT00069784A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy [clinicaltrials:NCT00069888]Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) [clinicaltrials:NCT00070655]SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis [clinicaltrials:NCT00071279]EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization [clinicaltrials:NCT00077753]Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) [clinicaltrials:NCT00077792]PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) [clinicaltrials:NCT00077805]Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE) [clinicaltrials:NCT00077818]Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE) [clinicaltrials:NCT00077844]Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer [clinicaltrials:NCT00081796]Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00087802]Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment [clinicaltrials:NCT00087958]HP184 in Chronic Spinal Cord Injury Subjects [clinicaltrials:NCT00093275]Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer [clinicaltrials:NCT00094081]Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function [clinicaltrials:NCT00094965]18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type [clinicaltrials:NCT00103649]Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type [clinicaltrials:NCT00104013]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
clinicaltrials:NCT00021255Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe Disease [clinicaltrials:NCT00025896]Clinical Trial in Males With BPH (Enlarged Prostate) [clinicaltrials:NCT00029822]Obese Patients With Untreated Dyslipidemias [clinicaltrials:NCT00029835]Obese Patients With Type 2 Diabetes [clinicaltrials:NCT00029848]Obese Patients With or Without Comorbidities (RIO-North America) [clinicaltrials:NCT00029861]Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [clinicaltrials:NCT00032734]Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT). [clinicaltrials:NCT00032747]A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea [clinicaltrials:NCT00034294]Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL) [clinicaltrials:NCT00042341]Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients [clinicaltrials:NCT00042354]Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis [clinicaltrials:NCT00043706]SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes [clinicaltrials:NCT00043784]Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione [clinicaltrials:NCT00044447]Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [clinicaltrials:NCT00044811]Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma [clinicaltrials:NCT00044824]Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00044889]Long-Term Safety Performance of Fexofenadine in Asthma [clinicaltrials:NCT00045955]12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes. [clinicaltrials:NCT00046150]Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment [clinicaltrials:NCT00046462]Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents [clinicaltrials:NCT00046501]Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia [clinicaltrials:NCT00046683]A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors. [clinicaltrials:NCT00046696]Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney Cancer [clinicaltrials:NCT00050323]clinicaltrials:NCT00050778Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) [clinicaltrials:NCT00050817]Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00051701]A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II [clinicaltrials:NCT00051935]clinicaltrials:NCT00053482clinicaltrials:NCT00053495Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination [clinicaltrials:NCT00053508]rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease) [clinicaltrials:NCT00053573]A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease [clinicaltrials:NCT00059280]SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism [clinicaltrials:NCT00062803]Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT) [clinicaltrials:NCT00067093]Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic Melanoma [clinicaltrials:NCT00068211]clinicaltrials:NCT00069784Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia [clinicaltrials:NCT00069862]A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy [clinicaltrials:NCT00069888]Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) [clinicaltrials:NCT00070655]
source [clinicaltrials_vocabulary:source]
Sanofi [clinicaltrials_resource:26fba9456e1e33d5671ff7055ed23621]
Bio2RDF identifier
26fba9456e1e33d5671ff7055ed23621
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:26fba9456e1e33d5671ff7055ed23621
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:26fba9456e1e33d5671ff7055ed23621
title
Sanofi
@en
type
label
Sanofi [clinicaltrials_resource:26fba9456e1e33d5671ff7055ed23621]
@en